Navigation Links
Unique Cardiovascular Treatment Readied for Global Market: Proprietary Paccocath(R) Technology is the Only Drug Eluting Balloon with Clinical Data
Date:5/18/2009

ns. The Paccocath technology continues to be the most studied and best understood and we believe that such careful characterization is important to ensure patient safety and improved outcomes."

Another major milestone in bringing Paccocath technology to market has been the completion of a balloon coating Center of Excellence facility in Minneapolis, Minnesota, which is the primary site for balloon coating and the development of future coating technologies and drug formulations. "Our investments in Paccocath technology research and in the development of the Cotavance product demonstrate our commitment to drug-eluting balloon technology and our intent to bring the best therapy to market," said McEwen.

Expanding the Paccocath technology to patients with heart disease, B.Braun Melsungen AG (Berlin, Germany) has licensed the technology for use in its SeQuent(R) Please drug eluting balloon catheter, which recently received CE certification for the treatment of narrowing of the coronary arteries. Adding to the clinical evidence in support of the Paccocath technology, B. Braun conducted the PEPCAD clinical studies, which provided evidence in support of its use in coronary arteries.

About MEDRAD Interventional/Possis

Possis Medical, a pioneer in the field of thrombus removal, has recently merged with MEDRAD, the leader in diagnostic and interventional contrast injection. Together, they have formed MEDRAD Interventional / Possis, a division of MEDRAD, INC., focused on advancing interventional medicine through research and innovation. With manufacturing facilities in both Minneapolis, MN and Pittsburgh, PA, MEDRAD Interventional / Possis manufactures and markets segment-leading medical devices such as AngioJet(R) Thrombectomy Systems, MEDRAD Avanta(R) Fluid Management Injector Systems, Mark V ProVis(R) Angiographic Contrast Injectors, the GuardDOG (R) Occlusion System, FETCH(R) Aspiration Catheters and the Saf
'/>"/>

SOURCE MEDRAD
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. CDC Analysis Finds Unique Social and Behavior Intervention Helps Reduce MRSA Rates Up to 62% in Study Hospitals
2. Healthpoint Initiates Phase II, Dose-Finding Study to Evaluate Effectiveness of a Unique Cell Based Therapy in Venous Leg Ulcers
3. IlluminOss Medical Announces First Human Case Utilizing a Unique, New, Minimally Invasive Technology for Fracture Repair is Performed at Medical Hospital del Trabajadar in Santiago, Chile
4. Unique Hearing Aid Receives Patent Protection
5. Peregrine Researchers Present New Preclinical Data at AACR Annual Meeting Confirming Unique Anti-Tumor Mechanism of Bavituximab
6. ANX-201 Demonstrates a Unique Resistance Profile in Preclinical Tests
7. Spit for the Cure Offers Unique Opportunity for Women to Participate in Breast Cancer Research
8. Taking a Hard-Line Approach to Cardiovascular Risks in the Diabetes Patient
9. Task Force Recommends Using Aspirin to Prevent Cardiovascular Disease When the Benefits Outweigh the Harms
10. VIA Pharmaceuticals Announces Positive Results of Phase 2 Studies of VIA-2291 in Patients With Serious Cardiovascular Disease
11. Physicians Health Study II Finds No Magic Bullet for Preventing Cardiovascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... , July 29, 2014 Regado Biosciences, Inc. ... on the Phase 3 clinical development of Revolixys™ Kit ... drug system, today announced that it will hold a ... 12, 2014, at 8:30 a.m. EDT to discuss its ... Interested participants and investors may access the conference ...
(Date:7/29/2014)... 2014  Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ... healthcare conferences during the third quarter, the 2014 Avondale ... Healthcare 2014 Conference.  Alexza,s corporate presentation will be webcast ... each event are below: , 2014 Avondale ... Boston , MA.  The format is ...
(Date:7/29/2014)... July 29, 2014  Landauer, Inc. (NYSE: ... radiation measurement and monitoring, outsourced medical physics services and ... for the fiscal third quarter 2014 after the market ... The Company will host a conference call for investors ... Time (10 a.m. Eastern Time). Investors may access the ...
Breaking Medicine Technology:Regado Biosciences to Provide Second Quarter 2014 Financial Results and Corporate Highlights 2Regado Biosciences to Provide Second Quarter 2014 Financial Results and Corporate Highlights 3Alexza Pharmaceuticals Announces Participation in Upcoming Investor Conferences 2Alexza Pharmaceuticals Announces Participation in Upcoming Investor Conferences 3Landauer, Inc. Sets Date and Time for Announcement of Fiscal Third Quarter 2014 Results 2
... , MIAMI , July 21 Understanding ... patient resources. That,s why Puerto Rican actress, author and mother ... partnered with the Asthma and Allergy Foundation of America (AAFA) ... new Spanish asthma education web resource to help patients learn ...
... Trinity Orthopedics LLC, a medical device company that develops and markets ... a Notice of Allowance from the U.S. Patent and Trademark Office for ... posterior fixation system in the United States under the ReStor ... "Recent clinical studies ...
Cached Medicine Technology:Latina Actress and Author Dayanara Torres Launches Online Asthma Education Resource for Hispanic Community in Partnership with Merck and AAFA 2Latina Actress and Author Dayanara Torres Launches Online Asthma Education Resource for Hispanic Community in Partnership with Merck and AAFA 3Latina Actress and Author Dayanara Torres Launches Online Asthma Education Resource for Hispanic Community in Partnership with Merck and AAFA 4Latina Actress and Author Dayanara Torres Launches Online Asthma Education Resource for Hispanic Community in Partnership with Merck and AAFA 5Latina Actress and Author Dayanara Torres Launches Online Asthma Education Resource for Hispanic Community in Partnership with Merck and AAFA 6Trinity Orthopedics Receives Patent Allowance for Sagittally Stable Spinal Fixation System 2
(Date:7/29/2014)... Advertising claims for cosmetic procedures using stem cells ... safety and effectiveness, according to a review in the ... , the official medical journal of the ... cells offer tremendous potential, but the marketplace is saturated ... patients at risk," write Dr Michael T. Longaker of ...
(Date:7/29/2014)... According to a July 22, 2014 ... “From Kim’s Butt to Angelina’s Lips: The Plastic Surgery ... the celebrity feature most requested by women seeking cosmetic ... Jennifer Lawrence’s nose, and Angelina Jolie’s ... data collected by an online community focused on plastic ...
(Date:7/29/2014)... York, New York (PRWEB) July 29, 2014 ... on behalf of individuals who allegedly suffered serious ... medications continue to move forward in a multidistrict ... of Pennsylvania, Bernstein Liebhard LLP reports. According to ... revised certain deadlines pertaining to bellwether case ...
(Date:7/29/2014)... 2014 Avenidas is always looking ... Once again, the non-profit agency is doing just that with ... seniors. , This event gives seniors the opportunity to learn ... There will be a variety of fun activities, including a ... demonstrations and artists. In addition, there will be food tastings, ...
(Date:7/29/2014)... Virginia Commonwealth University School of Medicine researchers have ... against the debilitating and potentially deadly tick-transmitted disease, ... several years, experts have seen a steady rise ... tick-transmitted bacterial pathogens making the need for ... knowing what to target to prevent disease, and ...
Breaking Medicine News(10 mins):Health News:Beware of claims about cosmetic stem cells procedures, says review in Plastic and Reconstructive Surgery 2Health News:Celebrity Plastic Surgery: Kim Kardashian’s Butt Tops the List of Celebrity Plastic Surgery Requests 2Health News:Tylenol Lawsuit News: Federal Court Overseeing Tylenol Liver Damage Claims Sets New Deadlines Pertaining to Discovery, Bellwether Trials, Bernstein Liebhard LLP Reports 2Health News:Tylenol Lawsuit News: Federal Court Overseeing Tylenol Liver Damage Claims Sets New Deadlines Pertaining to Discovery, Bellwether Trials, Bernstein Liebhard LLP Reports 3Health News:Tylenol Lawsuit News: Federal Court Overseeing Tylenol Liver Damage Claims Sets New Deadlines Pertaining to Discovery, Bellwether Trials, Bernstein Liebhard LLP Reports 4Health News:Avenidas Hosts Third Annual Successful Aging Celebration 2Health News:Researchers take steps toward development of a vaccine against tick-transmitted disease 2Health News:Researchers take steps toward development of a vaccine against tick-transmitted disease 3
... ALEXANDRIA, Va., Oct. 8 The National,Community Pharmacists ... two-term incumbent representing Illinois, for re-election to the,U.S. ... CEO of NCPA,issued the following statement:, "Senator ... and,America,s community pharmacies and the patients they serve. ...
... Pharmacists Association (NCPA) is endorsing Sen. Gordon Smith,(R-OR), ... the,U.S. Senate. Bruce Roberts, RPh, executive vice president ... "Senator Gordon Smith is a powerful advocate for ... serve. That is why the National,Community Pharmacists Association ...
... Inc. (OTCPK:,SNDY) is pleased to announce that the Company ... ending June 30, 2008. Revenues,generated through the first six-months ... comparable period in 2007. The Company,saw an increase in ... just,over $8,000 at the end of fiscal year 2007., ...
... are no safe substitutes for authentic,FDA approved injectables, ... and counterfeit cosmetic injectables are a threat to ... for Injectable Safety. "The,growing acceptance of cosmetic injections ... with consumer cautions," says Coalition,leader, plastic surgeon Jeffrey ...
... Extreme heat events (EHE), or heat waves, are the ... United States, responsible for more deaths annually than hurricanes, ... other climate-related changes in the worldwide environment that directly ... of the American Journal of Preventive Medicine . ...
... Kong Celebrates a Wealth of Innovative Products, HONG ... leader in,research and development, announces today that it will ... 2008 at Gordon Wu Hall, B P,International House to ... in 1902 in Minnesota, United States, 3M has an ...
Cached Medicine News:Health News:Solos Endoscopy, Inc. Posts First Six Months Financials of 2008 on Pinksheets.com 2Health News:Illegal Botox Scammers a Public Threat 2Health News:Illegal Botox Scammers a Public Threat 3Health News:Illegal Botox Scammers a Public Threat 4Health News:Illegal Botox Scammers a Public Threat 5Health News:Climate change will affect public health -- a call to action 2Health News:Climate change will affect public health -- a call to action 3Health News:3M Innovation Day 2Health News:3M Innovation Day 3
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
20 GA TITANIUM RETINAL FORCEPS...
Medicine Products: